论文部分内容阅读
目的:探讨膀胱尿路上皮癌伴鳞状分化的临床病理特点及预后;方法:回顾性分析我院2010年-2015年膀胱尿路上皮癌伴鳞状分化患者208例列入伴鳞状分化组,根据临床资料和手术方式,按照1:1匹配原则选取208例单纯膀胱尿路上皮癌患者作为对照组。研究组和对照组均行针对性治疗,随访6个月-3年,嘱定期入院复查;结果:伴鳞状分化组TURBT后的无复发生存率显著优于对照组(P<0.05);结论:膀胱尿路上皮癌伴鳞状分化的恶性程度高,复发率高,发生进展的风险高于单纯性膀胱尿路上皮癌,术后应密切随访。
Objective: To investigate the clinicopathological features and prognosis of bladder urothelial carcinoma with squamous differentiation.Methods: A retrospective analysis of 208 cases of urothelial carcinoma with squamous cell carcinoma in our hospital from 2010 to 2015 was included in the cases with squamous differentiation , According to the clinical data and surgical methods, according to the principle of 1: 1 matching 208 cases of bladder urothelial carcinoma as control group. The study group and the control group were targeted treatment, followed up for 6 months to 3 years, ordered regular hospital admission; Results: The recurrence-free survival rate after TURBT with squamous differentiation group was significantly better than the control group (P <0.05); Conclusion : Bladder urothelial carcinoma with squamous cell carcinoma of the high degree of malignancy, high recurrence rate, the risk of progression is higher than simple bladder urothelial carcinoma, should be followed up closely.